1-500 | 501-577
    Part,  Chapter, Paragraph

  1    -,     1            |            ii) produced through a 3-year process (from 15 November
  2    I,     2.  4.  0(1) |           CAT_PREREL/PGE_CAT_PREREL_YEAR_2009/PGE_CAT_PREREL_YEAR_
  3    I,     2.  4.  0(1) |            YEAR_2009/PGE_CAT_PREREL_YEAR_2009_MONTH_02/2-13022009-
  4    I,     2.  5        |         shrink by 20 million by the year 2030, even taking into account
  5    I,     2.  5        |       immigrating into the EU every year.~ ~According to recent European
  6    I,     2.  5.  0(3) |           CAT_PREREL/PGE_CAT_PREREL_YEAR_2008/PGE_CAT_PREREL_YEAR_
  7    I,     2.  5.  0(3) |            YEAR_2008/PGE_CAT_PREREL_YEAR_2008_MONTH_12/2-16122008-
  8    I,     2.  7        |             power. Moreover, only a year ago it was announced that
  9    I,     2.  9        |             has increased to 3.1 mm/year in the past 15 years (compared
 10    I,     2.  9        |            global average of 1.7 mm/year in the 20th century). Because
 11    I,     2. 10.  4    |          may cost around £2 billion/year in hospital stay alone.
 12    I,     2. 10.  4    |         alone. About 400 people per year die, or are seriously injured,
 13    I,     3.  1        |             women born in a certain year (birth cohort) postpone
 14    I,     3.  1        |            rate for that particular year (period TFR) is lower, but
 15    I,     3.  3        |     negative development (-0.4% per year) over the period of observation.
 16    I,     3.  3        |           will increase by 2.3% per year. The countries with the
 17   II,     4.  1        |                Table 4.1.3 shows 10-year trends in life expectancy
 18   II,     4.  1        |            of values estimated each year at MS level within EU27.~ ~
 19   II,     4.  1        |            per gender~ ~Over the 10 year period 1995-2005, life expectancy
 20   II,     4.  1        |           longevity gender gap by 1 year (Table 4.1.3). Estimates
 21   II,     4.  1        |     limitations, including over one year more with severe limitations.
 22   II,     4.  1        |          Women’s LE at birth is one year higher in the EU27 compared
 23   II,     4.  1        |         life expectancy over the 10-year period 1995-2005 and the
 24   II,     4.  2        |           expectancy in 1970 is one year higher, the average annual
 25   II,     5.  2.  1    |            4,30 million deaths each year in Europe and more than
 26   II,     5.  2.  1    |             2.0 million deaths each year within the European Union (
 27   II,     5.  2.  1    |           over 741,000 deaths every year (one in six men and over
 28   II,     5.  2.  1    |             for 508,000 deaths each year: around one in ten men and
 29   II,     5.  2.  2    |      present the data for the three year period 2001-2003 along with
 30   II,     5.  2.  2    |           for all ages for the last year available (2003) are reported.
 31   II,     5.  2.  2    |     European Society of Cardiology, year 2000, which is the last
 32   II,     5.  2.  2    |             2000, which is the last year for which accurate data
 33   II,     5.  2.  2    |        events rates derived from 10-year surveillance (from mid 1980s
 34   II,     5.  2.  2    |           for all ages for the last year available (2003) are reported.~
 35   II,     5.  2.  3    |           over 741.000 deaths every year: one in six men and one
 36   II,     5.  2.  3    |          ages combined for the last year available (htt b, 2007).
 37   II,     5.  2.  3    |            IHD,AMI, and stroke Last year available, all ages~ ~Revascularization
 38   II,     5.  2.  3    |             Men and women combined (year 2000)~ ~The only available
 39   II,     5.  2.  3    |             mean attack rates of 10-year surveillance for coronary
 40   II,     5.  2.  3    |     continued to collect data every year while others did it periodically.
 41   II,     5.  2.  3    |       events) per 100.000 during 10-year registration in men and
 42   II,     5.  2.  3    |            over 508.000 deaths each year. Around one in ten men and
 43   II,     5.  2.  3    |          ages combined for the last year available (htt b, 2007).
 44   II,     5.  2.  3    |             last 3 years of the 10- year surveillance in men and
 45   II,     5.  2.  5    |             IHD mortality over a 20-year period in England and Wales.
 46   II,     5.  2.  7    |          Medicare costs in the last year of life. Arch Intern Med
 47   II,     5.  2.  7    |           profile (Low Risk) and 10-year stroke incidence in women
 48   II,     5.  2.  7    |  cardiovascular risk profile and 10-year coronary heart disease incidence
 49   II,     5.  2.  7    |         heart disease mortality: 10-year results from 37 WHO MONICA
 50   II,     5.  3.  1    |          number of new cancers in a year over the population at risk.
 51   II,     5.  3.  1    |      underlying cause of death in a year over the population at risk.
 52   II,     5.  3.  1    |            cancer diagnosis (i.e. 1-year, 3-years, 5-years after
 53   II,     5.  3.  3    |          European countries for the year 2006 (Ferlay et al, 2007).~-
 54   II,     5.  3.  3    |            supplied by the WHO.~- 5-year relative survival for men
 55   II,     5.  3.  3    |          incidence, mortality and 5-year relative survival show European
 56   II,     5.  3.  6    |              Sex-and-age-adjusted 5-year survival trends for all
 57   II,     5.  3.  6    |        reason Figures 5.3.29 show 5-year relative survival for all
 58   II,     5.  3.  6    |          than men. Countries with 5-year relative survival higher
 59   II,     5.  3.  6    |             and site-standardized 5-year relative survival by sex.
 60   II,     5.  3.  6    |             and site-standardized 5-year relative survival by sex.
 61   II,     5.  3.  6    |       prognosis (Figures 5.3.30). 5-year relative survival was higher
 62   II,     5.  3.  6    |             151) age-standardized 5-year relative survival by sex.
 63   II,     5.  3.  6    |             151) age-standardized 5-year relative survival by sex.
 64   II,     5.  3.  6    |          December 1999 B) Women~ ~5-year colorectal cancer relative
 65   II,     5.  3.  6    |           indicate that in Europe 5-year relative survival for colorectal
 66   II,     5.  3.  6    |             154) age-standardized 5-year relative survival by sex.
 67   II,     5.  3.  6    |             154) age-standardized 5-year relative survival by sex.
 68   II,     5.  3.  6    |           poor, with age-adjusted 5-year relative survival ~10% in
 69   II,     5.  3.  6    |             5.3.32). Estimates of 1-year relative survival are ~30%
 70   II,     5.  3.  6    |     survival improvement in time. 5-year age-adjusted relative survival
 71   II,     5.  3.  6    |             162) age-standardized 5-year relative survival by sex.
 72   II,     5.  3.  6    |             162) age-standardized 5-year relative survival by sex.
 73   II,     5.  3.  6    |             relatively good, with 5-year relative survival (Figure
 74   II,     5.  3.  6    |            Malta and Portugal had 5-year age-standardised survival
 75   II,     5.  3.  6    |       Slovakia and Slovenia) with 5-year relative survival rate between
 76   II,     5.  3.  6    |             174) age-standardized 5-year relative survival. Patients
 77   II,     5.  3.  6    |           to 31st December 1999~ ~5-year relative survival for cervical
 78   II,     5.  3.  6    |             180) age-standardized 5-year relative survival. Patients
 79   II,     5.  3.  6    |           at 67% (Figure 5.3.35). 5-year relative survival rates
 80   II,     5.  3.  6    |            et al, 2003). European 5-year relative survival increased
 81   II,     5.  3.  6    |          Exceptional increases in 5-year relative survival for prostate
 82   II,     5.  3.  6    |             185) age-standardized 5-year relative survival. Patients
 83   II,     5.  3.  6    |      December, 2003.~Age-adjusted 5-year relative survival for colorectal (
 84   II,     5.  3.  6    |             the EUROCARE-4 study. 5-year period relative survival
 85   II,     5.  3.  6    |             cancers, age-adjusted 5-year period survival improved
 86   II,     5.  3.  6    |        cancers. The European mean 5-year relative survival was 79%
 87   II,     5.  3.  7    |            plans in place in EU and year of adoption in 27 EU Member
 88   II,     5.  4.  1    |             develop diabetes in one year. For IGT, the IDF reports
 89   II,     5.  4.  2    |         population outcomes.~In the year 1989, increasing awareness
 90   II,     5.  4.  2    |          diabetes in children (0-14 year), with type 1 and 2 not
 91   II,     5.  4.  2    |         diabetes in children in one year per 100.000 children.~Prevalence
 92   II,     5.  4.  2    |           cases of blindness in one year due to diabetic retinopathy/
 93   II,     5.  4.  2    |            of blindness in the same year tracked by independent blindness
 94   II,     5.  4.  2    |          diabetic population in one year.~Prevalence (stock) of dialysis/
 95   II,     5.  4.  2    |             diabetes mellitus by 10 year age bands~2~IV Epidemiology
 96   II,     5.  4.  2    |         should be also tested every year. The clinical management
 97   II,     5.  4.  2    |          diabetic population in one year. Amputations are also recorded
 98   II,     5.  4.  2    |          diabetic population in one year.~The annual incidence of
 99   II,     5.  4.  2    |          diabetic population in one year.~ ~
100   II,     5.  4.  3    |          diabetes in children (0-14 year). Standardised incidence
101   II,     5.  4.  3    |      Finland) cases per 100,000 per year. The median value is 18 (
102   II,     5.  4.  4    |         would loose 30 citizens per year due to diabetes.~As far
103   II,     5.  4.  4    |             develop diabetes in one year. Clinical management can
104   II,     5.  4.  6    |            Day to be observed every year starting in 2007.~ ~
105   II,     5.  4.  8    |         diabetes: estimates for the year 2000 and projections for
106   II,     5.  5.Int    |         total of €300 billion every year in ill-health and lost productivity.
107   II,     5.  5.Int    |          Actions under the European Year for People with Disabilities
108   II,     5.  5.  1    |            services in the previous year (Alonso et al, 2004b). Of
109   II,     5.  5.  1    |             rates (WHO, most recent year available as of 2007). Lithuania,
110   II,     5.  5.  1    |            at the end of a calendar year as registered by ICD-9/10.
111   II,     5.  5.  1    |             varies according to the year.~ ~· Eurostat~ ~Suicide.
112   II,     5.  5.  1    |          data is available for five year age cohorts, for both sexes
113   II,     5.  5.  1    |         score MH<55 in elderly (65+ year old) with reference to 25-
114   II,     5.  5.  1    |             with reference to 25-64 year old population, by country
115   II,     5.  5.  2    |             women combined, in five year age groups from 60 to 84
116   II,     5.  5.  2    |     separate prevalence rates per 5 year age groups up to the age
117   II,     5.  5.  2    |    separately from 30 to 99 in five year age groups. Once extracted,
118   II,     5.  5.  2    |         Framework Programme for a 3 year project entitledEuropean
119   II,     5.  5.  3    |   prospective cohort study with a 5 year follow-up for Goteborg shows
120   II,     5.  5.  3    |            data is derived from the year 2005), data from countries
121   II,     5.  5.  3    |          onset of schizophrenia per year; thus the incidence rate
122   II,     5.  5.  3    |           from data of 2002 for the year 2005: In the WHO European
123   II,     5.  5.  3    |            of antipsychotics in the year 2002.~The gap between evidence
124   II,     5.  5.  3    |             health care service for year 2002 and 2004 with respect
125   II,     5.  5.  3    |       condition occurring in 3 to 4 year olds characterized by deterioration,
126   II,     5.  5.  3    |             geographic areas, using year of birth as a reference
127   II,     5.  5.  3    |             Commission the previous year began its work.~The central
128   II,     5.  5.  3    |      incidence 23.5 per 100,000 per year). Undetermined epilepsy (
129   II,     5.  5.  3    |            15% (8.7 per 100,000 per year), cryptogenic localization-related
130   II,     5.  5.  3    |            16% (8.8 per 100,000 per year), symptomatic localization-related
131   II,     5.  5.  3    |            15% (8.4 per 100,000 per year), and idiopathic generalized
132   II,     5.  5.  3    |             6% (3.4 per 100,000 per year). In Bordeaux, France, the
133   II,     5.  5.  3    |            per 1,000)~Reference(s), year~ ~Denmark ~All ages ~MR
134   II,     5.  5.  3    |          per 100,000 population per year, but international vital
135   II,     5.  5.  3    |         compared with patients in 5-year remission. There is also
136   II,     5.  5.  3    |            event occurring in a 1-2 year period in a large cohort
137   II,     5.  5.  3    |         reported a 69% cumulative 5-year remission rate at 9 years
138   II,     5.  5.  3    |       Cockerell et al, 1995). The 5-year remission rate at 10 years
139   II,     5.  5.  3    |            al, 2001) and the 3 to 5-year remission rate at 12-30
140   II,     5.  5.  3    |              64% of cases were in 5-year terminal remission off medications (
141   II,     5.  5.  3    |  intelligence exhibiting at least 2-year retardation in reading skills (
142   II,     5.  5.  3    |       during sleep (license valid 1 year;~ 2 years if seizure freedom >
143   II,     5.  5.  3    |       during sleep established by 1 year~Italy I 24 months -~ II -
144   II,     5.  5.  3    |              Incidence (per 100 000/year) of Multiple Sclerosis in
145   II,     5.  5.  3    |         from 3 to 6 per 100 000 per year in the western regions in
146   II,     5.  5.  3    |            have persisted over a 30-year follow-up period, with the
147   II,     5.  5.  3    |           MS.~Iceland provides a 50-year observational period in
148   II,     5.  5.  3    |        between 1990-2001, with a 15-year shorter life expectancy
149   II,     5.  5.  3    |       economic burden of MS for the year 2005 was €13 billion, i.e., €
150   II,     5.  5.  3    |         total cost of MS in Europe (year 2005) by resource use components.~ ~
151   II,     5.  5.  3    |       proportion) costs14 300 per year, €31 200 per year if with
152   II,     5.  5.  3    |           300 per year, €31 200 per year if with moderate disability,
153   II,     5.  5.  3    |         disability, and €58 300 per year if with severe disability.~ ~
154   II,     5.  5.  3    |      recently embarked upon a three year project entitled MS-ID (
155   II,     5.  5.  3    |           total population-based 50 year prospective study. Clinical
156   II,     5.  5.  3    |             and incidence over a 25-year period. Eur J Neurol 8:463-
157   II,     5.  5.  3    |      Aarseth JH, et al (2006): A 50-year follow-up of the incidence
158   II,     5.  5.  3    |            Sclerosis Registry: a 50-year follow-up. Mult Scler 5:
159   II,     5.  5.  3    |    sclerosis in Padova, Italy: a 30-year epidemiological survey.
160   II,     5.  5.  3    |      resulting in €10.7 billion per year in Europe (Andlin-Sobocki
161   II,     5.  5.  3    |            and 11 to 19/100,000 per year, respectively. When only
162   II,     5.  5.  3    |      followed PD patients over a 10-year time-period, reports that
163   II,     5.  5.  3    |            Hely et al, 1999). The 5-year survival rate in a cohort
164   II,     5.  5.  3    |             rate was 42% and the 15 year survival rate was 23%. Risk
165   II,     5.  6.  3    |            pain during the previous year, whereas 58% reported musculoskeletal
166   II,     5.  6.  3    |             day during the previous year ( Natvig et al, 1995). They
167   II,     5.  6.  3    |             lifetime risk or the 10 year probability of fracture
168   II,     5.  6.  3    |      vertebral deformity are 1% per year among women and 0.6% per
169   II,     5.  6.  3    |            among women and 0.6% per year among men from the European
170   II,     5.  6.  3    |          Table 5.6.10. Estimated 10 year risks of fractures in the
171   II,     5.  6.  3    |      replacement of the joint. At 1 year, hip fracture is associated
172   II,     5.  6.  3    |       fracture is high in the first year, perhaps up to 25% in women
173   II,     5.  6.  3    |          this is gradual over the 5 year period. No excess mortality
174   II,     5.  6.  3    |         affecting 2044% within 1 year in the working population
175   II,     5.  6.  3    |          episodes / 1000 people per year; the incidence of low back
176   II,     5.  6.  3    |          was 11.6 / 1000 people per year, affecting men a little
177   II,     5.  6.  6    |             functional recovery one year following hospital discharge
178   II,     5.  6.  6    |            prospective study over 1 year. Osteoporos Int 3:148-153~
179   II,     5.  6.  6    |            of Osteoarthritis in the Year 2000. Available at URL: htt f.
180   II,     5.  7.  1    |             of $26.000 per case per year in the USA (Smith et al,
181   II,     5.  7.  3    | corresponding figure was 7.7 cases /year pmarp (<30 ml/min per 1.
182   II,     5.  7.  5    |        figures indicate that in the year up to to March 2007,the
183   II,     5.  8.  1    |            300 000 people die every year in Europe because of COPD.
184   II,     5.  8.  3    |            in Northern Sweden, a 10-year cumulative incidence rate
185   II,     5.  8.  3    |   individuals was considered: the 7-year cumulative incidence of
186   II,     5.  8.  3    |            in never smokers, in a 9-year follow-up of a general population
187   II,     5.  8.  3    |             Countries Study, the 30-year cumulative incidences of
188   II,     5.  8.  3    |       smokers (9% in women). The 25-year cumulative incidence of
189   II,     5.  8.  3    |          population sample of 25-73 year old patients from Northern
190   II,     5.  8.  3    |   obstructive lung disease in 40-69 year olds to 14.4% (6.3% COPD) (
191   II,     5.  8.  3    |           and emphysema in the past year among adults in seven EU
192   II,     5.  8.  3    |           and emphysema in the past year, namely: asthma, allergy,
193   II,     5.  8.  3    |     frequency > 1% within the first year after diagnosis was pointed
194   II,     5.  8.  3    |         estimated at 4,366 euro per year: 41% was directed to COPD
195   II,     5.  8.  3    |           cost for treatment of 40+ year patients, 10% was directed
196   II,     5.  8.  4    |          former Jugoslavia), the 30-year cumulative incidences of
197   II,     5.  8.  4    |      smokers (31% in women). The 25-year cumulative incidence of
198   II,     5.  8.  4    |             spread rapidly in 20-44 year old women. This was confirmed
199   II,     5.  8.  5    |             2002). During the first year after smoking cessation,
200   II,     5.  8.  5    |             present in 24.3% of 40+ year old smokers with a smoking
201   II,     5.  8.  5    |              which is updated every year by GOLD (GOLD, 2006).~ ~
202   II,     5.  8.  7    |               Developing COPD: a 25 year follow up study of the general
203   II,     5.  8.  7    |          and COPD in relation to 30-year pulmonary function and 40-
204   II,     5.  8.  7    |           pulmonary function and 40-year mortality: a follow-up in
205   II,     5.  9.  2    |       performed. ECRHS II is a nine year follow-up prospective survey
206   II,     5.  9.  2    |          for the survey.~ ~From the year 2000 onwards few data have
207   II,     5.  9.  3    |            was 2.56/1000 people per year. Incidence peaked in boys
208   II,     5.  9.  3    |         years (4.38/1000 people per year) and in women aged 30 or
209   II,     5.  9.  3    |           more (3.1/1000 people per year) and showed a generational
210   II,     5.  9.  3    |         estimated to be 250,000 per year worldwide. EU mortality
211   II,     5.  9.  3    |           wheezing are visited in a year of observation, 44900 had
212   II,     5.  9.  3    |               at 45 billion euros a year. Allergies impair the quality
213   II,     5.  9.  4    |        cases per million people per year.~ ~The SCARPOL Study (Swiss
214   II,     5.  9.  4    |            pet keeping in the first year of life, particularly, dog
215   II,     5.  9.  7    |          fever, and eczema in 12-14 year olds in the British Isles,
216   II,     5. 11.  3    |         Lifetime prevalence=21.3% 1-year prevalence=6.7% Point prevalence=
217   II,     5. 11.  3    |          yrs)~Point prevalence=4%,1-year prevalence=10%~Yngveson
218   II,     5. 11.  3    |           yrs~Point prevalence=3%,1-year prevalence=9%~Mortz C, et
219   II,     5. 11.  3    |         primary prevention,. In the year 2004, altogether 11,643
220   II,     5. 11.  3    |             24.8% to 9.2% over a 12-year period (CS Jensen et al,
221   II,     5. 11.  3    |             below 30 years over a 9-year period (A Schnuch, and W
222   II,     5. 12.  2    |            the rates using calendar year as a regressor variable.
223   II,     5. 12.  2    |         data (litres of ethanol per year) for selected countries
224   II,     5. 12.  7    |           and simulated controls: 5-year survival. Multi-centre group.
225   II,     5. 13        |      life-years of ill health every year in the WHO Europe region.~ ~
226   II,     5. 13        |             to be €32.8 billion per year (Fry and Finley, 2005).
227   II,     5. 14.  2    |       dental clinic within the past year.~Numerator: Number of subjects
228   II,     5. 14.  3    |    management. In France, 40% of 12-year olds have no caries experience;
229   II,     5. 14.  3    |            random sample of 1379 12-year old children in Leicestershire
230   II,     5. 14.  3    |             dentist during the past year and this was found to be
231   II,     5. 15.  2    |      website. It is updated twice a year. The data is provided by
232   II,     5. 15.  3    |          deaths before the age of 1 year, to 9.6% of deaths between
233   II,     5. 15.  3    |         hospitalisations during the year 1999 in France. These are
234   II,     5. 15.  4    |             the incentives (e.g. 10-year market exclusivity, protocol
235   II,     6.  2        |            on official data for the year 2005 reported by the countries,
236   II,     6.  3.  2    |            a HCAI in the EU25 every year can be estimated at 3 000
237   II,     6.  3.  2    |           50 000 deaths occur every year as the consequence of the
238   II,     6.  3.  3    |          are becoming infected each year.~ ~Effective antiretroviral
239   II,     6.  3.  3    |           declined until around the year 2000 and since then has
240   II,     6.  3.  3    |           200 cases per 100 000 per year in 1995, to below 40 per
241   II,     6.  3.  3    |            below 40 per 100 000 per year in 2004. In the low-incidence
242   II,     6.  3.  3    |            5 to 2.2 per 100 000 per year in 2000, but has been rising
243   II,     6.  3.  3    |        reaching 3.1 per 100 000 per year in 2004, mainly due to outbreaks
244   II,     6.  3.  3    |            60 cases per 100 000 per year in 1995), a sharp decrease
245   II,     6.  3.  3    |            10 cases per 100 000 per year, with an overall decreasing
246   II,     6.  3.  3    |             6 cases per 100 000 per year over the period. However,
247   II,     6.  3.  3    |       generally infected within one year of their first injection.
248   II,     6.  3.  3    |            from 7.0 per 100 000 per year in 2001, to 7.9 per 100
249   II,     6.  3.  3    |              to 7.9 per 100 000 per year in 2004, but this increase
250   II,     6.  3.  3    |     incidence rates per 100 000 per year were reported by Ireland (
251   II,     6.  3.  4    |       influenza virus A and B. Each year there are epidemics during
252   II,     6.  3.  4    |             do occur throughout the year. Seasonal influenza poses
253   II,     6.  3.  4    |            below 20 per 100 000 per year since 2001 in all countries.~ ~
254   II,     6.  3.  4    |          rate of 13 per 100 000 per year, with a countrywide range
255   II,     6.  3.  4    |           rate (135 per 100 000 per year in 2005) and will effectively
256   II,     6.  3.  4    |          around one per 100 000 per year. In 2005, a total of 4 189
257   II,     6.  3.  4    |             of 3.36 per 100 000 per year was seen in Spain, followed
258   II,     6.  3.  4    |           with 2.38 per 100 000 per year. In 2005, 746 cases of travel-associated
259   II,     6.  3.  5    |           six cases per 100 000 per year, but this is a serious infectious
260   II,     6.  3.  5    |        several thousand deaths each year, especially in the very
261   II,     6.  3.  5    |           two cases per 100 000 per year. Good vaccines are only
262   II,     6.  3.  5    |    infections (5.83 per 100 000 per year) were reported by 19 countries.
263   II,     6.  3.  5    |          varied below 2/100 000 per year with stable trends or even
264   II,     6.  3.  5    |            was 4.10 per 100 000 per year. Thus pertussis, although
265   II,     6.  3.  5    |            1995 (15 per 100 000 per year) with a second peak in 2000 (
266   II,     6.  3.  5    |            2000 (11 per 100 000 per year). In Estonia and Lithuania
267   II,     6.  3.  5    |           below 0.2 per 100 000 per year in the EU15 states, except
268   II,     6.  3.  5    |          below 0.35 per 100 000 per year, except for Slovenia where
269   II,     6.  3.  5    |             at 0.45 per 100 000 per year in 2000 (nine cases) and
270   II,     6.  3.  5    |            with 0.5 per 100 000 per year in 2002 (two cases). In
271   II,     6.  3.  5    |           almost 35 per 100 000 per year before 1997 to less than
272   II,     6.  3.  5    |             than 10 per 100 000 per year after 1998 (Figure 6.6).~ ~
273   II,     6.  3.  5    |          most countries over the 10-year period. A recrudescence
274   II,     6.  3.  5    |         five and 42 per 100 000 per year. In the other countries,
275   II,     6.  3.  5    |          one and 10 per 100 000 per year since 2000.~ ~In 2005, a
276   II,     6.  3.  5    |            was 0.28 per 100 000 per year and the highest rates per
277   II,     6.  3.  5    |         below one per 1 000 000 per year during the past few years.~ ~
278   II,     6.  3.  5    |           in incidence over this 10-year period, notably Poland in
279   II,     6.  3.  5    |           was 17.65 per 100 000 per year.~ ~Rubella~ ~Rubella is
280   II,     6.  3.  5    |            was 0.51 per 100 000 per year, with Lithuania (3.44 per
281   II,     6.  3.  6    |             group appears to be 04 year one. In 2005, a total of
282   II,     6.  3.  6    |            was 2.23 per 100 000 per year, with children under five
283   II,     6.  3.  6    |     incidence (30.4 per 100 000 per year).~ ~Listeriosis~ ~Listeriosis
284   II,     6.  3.  6    |          2004 (0.28 per 100 000 per year) was similar to that for
285   II,     6.  3.  6    |          the most cases over the 10-year period. In 2005, a total
286   II,     6.  3.  6    |     reported ( 0.01 per 100 000 per year). In 2005, 34 cases were
287   II,     6.  3.  6    |           than five per 100 000 per year. The highest incidence was
288   II,     6.  3.  6    |          1995 (1.68 per 100 000 per year), and has shown a steadily
289   II,     6.  3.  7    |       increase of cases every third year. The year 2005 saw one of
290   II,     6.  3.  7    |         cases every third year. The year 2005 saw one of these peaks,
291   II,     6.  3.  7    |           reported for the whole 10-year period). The most cases
292   II,     6.  3.  7    |           more than seven cases per year were reported across the
293   II,     6.  3.  7    |             to 2.27 per 100 000 per year, with a steady decrease
294   II,     7.  1        |           treated for injuries each year and about 250,000 citizens
295   II,     7.  2.  4    |            with being the reference year 2004.~htt ~ ~
296   II,     7.  3.  1    |           treated for injuries each year; this is more than the whole
297   II,     7.  3.  2    |            of a million people each year. Injuries kill more children,
298   II,     7.  3.  2    |           lives could be saved each year if every country in the
299   II,     7.  3.  3    |           the EU27 are reported per year. A wide range of discharges
300   II,     7.  3.  4    |         fatalities are recorded per year in the EU27. They range
301   II,     7.  3.  4    |             In absolute terms every year more than 100 000 EU citizens
302   II,     7.  3.  5    |              almost 61 000 people a yearsee Figure 7.2 ) In Europe
303   II,     7.  4.  1    |             traumatic injuries each year (Working Group of Governmental
304   II,     7.  4.  1    |             total population. Every year more than 20 000 people
305   II,     7.  4.  2    |        direct medical costs~ ~Every year approximately 105 000 people
306   II,     7.  4.  2    |     treatment due to an injury each year, which represents about
307   II,     7.  4.  2    |           about 8 million cases per year in the EU27 (Working Group
308   II,     7.  4.  3    |          the burden of injury. Each year, 45 000 people are killed
309   II,     7.  7        |            EU27 excl. EE, IT, FI. 3 year average of 2003-2005. [https://
310   II,     7.  7        |        self-harm (X60-X84). EU27, 3 year average of the latest available
311   II,     7.  7        |          assault (X85-Y09). EU27, 3 year average of the latest available
312   II,     7.  7        |           work by severity. EU15, 3 year average of the latest available
313   II,     8.  1.  5    |           follow up to the European Year of People with Disabilities
314   II,     8.  2.  1    |         screening programme after 1 year. Journal of Intellectual
315   II,     8.  2.  2    |          avoidable blindness by the year 2020 and preventing the
316   II,     8.  2.  2    |            visual impairment in the year 2002. Bulletin of the World
317   II,     8.  2.  3    |     severity in the age group 15-19 year has been estimated to be
318   II,     8.  2.  3    |       burden of hearing loss in the year 2000 (on-line publication
319   II,     9            |           20 in 2005 or most recent year~ ~Fi ~ ~Differences between
320   II,     9            |     childhood rather than the first year of life. Special surveys
321   II,     9            |             Data from ESPAD from 16 year olds shows a range of persons
322   II,     9            |             from over a tenth of 11 year old boys in six countries
323   II,     9            |          countries to a fifth of 13 year old boys in eight countries
324   II,     9            |             in Context, only the 15 year olds were asked to respond
325   II,     9            |            condom use during the 15 year olds’ last intercourse are
326   II,     9.  1        |          000 die within their first year (EUROSTAT Database); Among
327   II,     9.  1.  1    |             of gestation in a given year per 1000 live and stillbirths
328   II,     9.  1.  1    |             stillbirths in the same year.~WHO recommends that registration
329   II,     9.  1.  1    |             of gestation in a given year, expressed per 1000 live
330   II,     9.  1.  1    |             live births in the same year. This rate is sub-divided
331   II,     9.  1.  1    |          weeks gestation in a given year expressed per 1000 live
332   II,     9.  1.  1    |             live births in the same year.~Same as neonatal mortality~ ~
333   II,     9.  1.  1    |            or most recent available year using EUROSTAT data, while
334   II,     9.  1.  1    |            countries based on their year of accession to the European
335   II,     9.  1.  1    |   proportion of deaths in the first year of life.~ ~Table 9.1.1.3.
336   II,     9.  1.  1    |    countries in 2005 or most recent year~ ~Congenital malformations~ ~
337   II,     9.  1.  1(1) |         from Cyprus is based on one year data (2005) and 25 deaths
338   II,     9.  1.  1    |            of neonatal deaths every year would be halved. Better
339   II,     9.  1.  2    |           birth or within the first year of life are the focus of
340   II,     9.  1.  2    |        total 1.4 million births per year. Annual birth coverage is
341   II,     9.  1.  2    |          000). EUROCAT updates each year prevalence figures on 95
342   II,     9.  1.  2    |           20 in 2005 or most recent year~ ~Figure 9.T1.2a. Percent
343   II,     9.  1.  2    |     childhood rather than the first year of life. Special surveys
344   II,     9.  2.  2    |            2. Data Sources~ ~In the year 2000 the European commission
345   II,     9.  2.  3    |              and accidents for 5-14 year olds (see Chapter 7).~ ~
346   II,     9.  2.  3    |        under 25 years of age. Every year, some 9.000 children and
347   II,     9.  2.  3    |             children is rising each year by 400 000 (European Commission,
348   II,     9.  2.  3    |             the number of times per year European children are being
349   II,     9.  2.  4    |             Data from ESPAD from 16 year olds shows a range of persons
350   II,     9.  2.  4    |             from over a tenth of 11 year old boys in six countries
351   II,     9.  2.  4    |          countries to a fifth of 13 year old boys in eight countries
352   II,     9.  2.  4    |             in Context, only the 15 year olds were asked to respond
353   II,     9.  2.  4    |            condom use during the 15 year olds’ last intercourse are
354   II,     9.  3.  1    |       oestradiol are maximal in the year of the final menstrual period (
355   II,     9.  3.  1    |      continues at all ages.~ ~Every year, about 5,500 people are
356   II,     9.  3.  1    |           some 58 000 citizens each year commit suicide, a number
357   II,     9.  3.  1    |            about 2 million deaths a year in the EU. These diseases
358   II,     9.  3.  1    |      approximately 7 000 deaths per year in men and women in England
359   II,     9.  3.  1    |          cause one million deaths a year in the WHO European Region;
360   II,     9.  3.  1    |           of the population) by the year 2010. Thus, obesity has
361   II,     9.  3.  1    |            than 300 000 deaths each year, while cancer of the corpus
362   II,     9.  3.  1    |            hip fractures occur each year, a number expected to double
363   II,     9.  3.  1(3) |             commence) and the first year after menopause. The climacteric
364   II,     9.  3.  1    |       Physicians noted that the one year mortality rate for men following
365   II,     9.  3.  1    |            least doubled within one year. Adequate nutrition – in
366   II,     9.  3.  1    |          may be secretory until the year before menopause. In postmenopausal
367   II,     9.  3.  1    |            concentration levels per year from young adulthood and
368   II,     9.  3.  2    |             1. Introduction~ ~Every year more than 5 million women
369   II,     9.  3.  2    |          mortality ratios after the year 2000 than in the early 1990s.
370   II,     9.  3.  2    |           al (2007): Neonatal and 5-year outcomes after birth at
371   II,     9.  3.  3    |           the age group of 14 to 17 year olds and their parents have
372   II,     9.  3.  3    |          had sexual intercourse, 15 year olds~ ~The percentage of
373   II,     9.  3.  3    |             partner during the last year. The highest proportion
374   II,     9.  3.  3    |             partner during the last year was in the 1990s close to
375   II,     9.  3.  3    |        condom usage during the past year, 22.4% of one thousand individuals
376   II,     9.  3.  3    |             men who during the last year were engaged in unprotected
377   II,     9.  3.  3    |           partners (during the last year, lifetime);~· condom use
378   II,     9.  3.  3    |   commercial sex worker in the last year;~· age mixing in sexual
379   II,     9.  3.  3    |          and contraception) in each year 1993, 1998 and 2003.~Wellings
380   II,     9.  4.  3    |             and analysis~ ~ ~By the year 2025 about one third of
381   II,     9.  4.  3    |           Group, 2003). In 70 to 79 year olds, the prevalence of
382   II,     9.  4.  3    |          notification rate in 45-64 year olds, and those over 64
383   II,     9.  4.  3    |        people at a rate of 1.5% per year. For those who are disabled,
384   II,     9.  5.  3    |            5.4. Percentage of 25-64 year old females with at least
385   II,     9.  5.  3    |          Francea~· 25,000 raped per year~Irelanda ( 2002 study )~·
386   II,     9.  5.  3    |            England and Wales in the year preceding interview, there
387   II,     9.  5.  3    |       countries need to provide one year of dementia care per person
388   II,     9.  5.  3    |        hospitalisations in the past year, with a total of about 10
389   II,     9.  5.  6    |            Health selection in a 14-year follow-up study - a question
390  III,    10.  2.  1    |           over 650,000 people every year in Europe. Many of these
391  III,    10.  2.  1    |      categories of diseases for the year 2000.~ ~Table 10.2.1.1.3.
392  III,    10.  2.  1    |  attributable to smoking, all ages, year 2000~ ~Smoking, along with
393  III,    10.  2.  1    |    tobacco-related illnesses by the year 2020 (Warren et al, 2006).~ ~
394  III,    10.  2.  1    |         that 79,500 people die each year in the EU as a result of
395  III,    10.  2.  1    |              130.31 billion for the year 2000, or about 1% of the
396  III,    10.  2.  1    |         money in tobacco taxes each year than they spend on anti-tobacco
397  III,    10.  2.  1    |       minimum of € 3 per capita per year on tobacco control.~· Countries
398  III,    10.  2.  1    |           over 650 000 people every year. Worldwide, it causes 5,
399  III,    10.  2.  1    |         litres of pure alcohol each year – a level over 2.5 times
400  III,    10.  2.  1    |        Twenty eight percent of past year EU25 drinkers (80 million
401  III,    10.  2.  1    |            occasion during previous year~ ~Of the two thirds of EU25
402  III,    10.  2.  1    |           of alcohol drunk by 15-16 year olds on the last drinking
403  III,    10.  2.  1    |          over 1 in 8 (13%) of 15-16 year old students have been drunk
404  III,    10.  2.  1    |         overall consumption.~ ~Each year in the European Union, it
405  III,    10.  2.  1    |            been estimated that each year in the European Union, alcohol
406  III,    10.  2.  1    |             whom die in the EU each year, Figure 10.2.1.2.4. This
407  III,    10.  2.  1    |        alcohol in EU per age group (year 2000)~ ~There is a substantial
408  III,    10.  2.  1    |             to be €125 billion each year, equivalent to 1.3% of GDP.
409  III,    10.  2.  1    |            Europe per cost element (year 2003)~ ~
410  III,    10.  2.  1    |             the intervention at six year follow-up.~ ~There is extensive
411  III,    10.  2.  1    |            Disability Adjusted Life Year~EMCDDA~European Monitoring
412  III,    10.  2.  1    |           data are summarized every year in an annual report on the
413  III,    10.  2.  1    |        users anymore. However, last year use of different drugs shows
414  III,    10.  2.  1    |             or younger. Among 15-16 year olds, lifetime (i.e. at
415  III,    10.  2.  1    |            for cannabis among 15-16 year olds. In most countries,
416  III,    10.  2.  1    |           among young adults (15-34 year old)~ ~Most drug use is
417  III,    10.  2.  1    |            taking place among 15-34 year olds and lifetime prevalence
418  III,    10.  2.  1    |            20%) used it in the last year (Figure 10.2.3.2) and over
419  III,    10.  2.  1    |            at least 5%. In the past year, 2.4% of young adults have
420  III,    10.  2.  1    |            and 1.5% and 2% for last year use. Lifetime prevalence
421  III,    10.  2.  1    |             1.3.2. Overview of last year drug prevalence estimates
422  III,    10.  2.  1    |          cocaine.~Increases in last year’s prevalence of cocaine
423  III,    10.  2.  1    |             2.1.3.3. Trends in last year prevalence of cocaine among
424  III,    10.  2.  1    |         between 0.5 and 6 cases per year for a population of 1 000
425  III,    10.  2.  1    |             3.5. AIDS incidence per year of diagnosis in EU Countries*,
426  III,    10.  2.  1    |           deaths were reported each year, adding up to more than
427  III,    10.  2.  1    |           during the last reporting year.~ ~Treatment demand17~ ~
428  III,    10.  2.  1    |                 Percentage of 15-19 year olds adolescents with bleeding
429  III,    10.  2.  1    |            than once a day among 13 year old schoolchildren in Nordic
430  III,    10.  2.  1    |           frequency from Finnish 12 year olds issue from the Finnish
431  III,    10.  2.  1    |             and Percentage of 15-19 year old adolescents with gingival
432  III,    10.  2.  1    |          observed among 5, 8 and 12 year olds. Among 15 year olds,
433  III,    10.  2.  1    |          and 12 year olds. Among 15 year olds, 56 per cent of 15
434  III,    10.  2.  1    |             olds, 56 per cent of 15 year old boys had some gingivitis,
435  III,    10.  2.  1    |       fluoride (250-750 ppm for 3-6 year old children) is an effective
436  III,    10.  2.  1    |     reporting; a standard reporting year; representativeness of the
437  III,    10.  2.  1    |            since 1994) every second year.~ ~ ~The quality of currently
438  III,    10.  2.  1    |            travelled per person per year on foot and by bicycle declined
439  III,    10.  2.  1    |    associated to 600 000 deaths per year (6% of total deaths) and
440  III,    10.  2.  1    |             150-300 per citizen per year (UK DCMS and Strategy Unit,
441  III,    10.  2.  1    |      life-years of ill health every year in the WHO Europe region.~ ~
442  III,    10.  2.  1    |             to be €32.8 billion per year (Fry and Finley, 2005).
443  III,    10.  2.  1    |         Country~Survey name~Acronym~Year~Subjects (number)~Age range~
444  III,    10.  2.  1    |            obesity in the 13 and 15 year olds from the HBSC survey
445  III,    10.  2.  1    |             0 percentage points per year (pp/y) based on measured
446  III,    10.  2.  1    |      life-years of ill health every year (WHO, 2002) In 2002, poor
447  III,    10.  2.  1    |            available throughout the year. Choices include the traditional
448  III,    10.  2.  5    |        haematic flow (about 1% each year after 50 years of age) and
449  III,    10.  2.  5    |              about 1 ml/minute each year after 40 years of age) due
450  III,    10.  3.  1    |            Disability-Adjusted Life Year. This integrated health
451  III,    10.  3.  1    |          cases of lung cancer every year. Most probable estimation
452  III,    10.  3.  1    |      ascribed to radon exposure per year (Barns, 2005). A pooled
453  III,    10.  3.  1    |            9% of lung cancer deaths/year in Europe can be ascribed
454  III,    10.  3.  1    |             deaths from lung cancer/year (Bray et al, 2002) makes
455  III,    10.  3.  1    |             30 000 deaths in Europe/year. Radon is also a well known
456  III,    10.  3.  1    |             children (age 0-14) per year. Whether changes of recommended
457  III,    10.  3.  2    |    increased by an average of 14% a year between 2000 and 2005 (WTO,
458  III,    10.  3.  2    |        varies between 20 and 30 per year (EU15) and shows no clear
459  III,    10.  3.  2    |             order of 5% or more per year, higher in countries with
460  III,    10.  3.  3    |       influenza and malaria). Every year approximately three million
461  III,    10.  3.  3    |       influenza virus A and B; each year there are epidemics during
462  III,    10.  3.  3    |             do occur throughout the year; seasonal influenza poses
463  III,    10.  3.  4    |          euro of economic loss each year in the WHO European Region.
464  III,    10.  3.  4    |    Estimated total damages of a 100-year flood are projected to increase
465  III,    10.  4.  1    |        Central Europe by almost one year and threatens the healthy
466  III,    10.  4.  1    |    premature deaths in Europe every year. Air pollution by fine particles
467  III,    10.  4.  1    |         2004 (or the last available year); Figure 10.4.1.2 shows
468  III,    10.  4.  1    |              2004 or last available year~Figu ~ ~Air pollution management
469  III,    10.  4.  1    |     expectancy may be more than one year.~ ~While much information
470  III,    10.  4.  1    |          around Euro 10 billion per year for the EU as a whole, if
471  III,    10.  4.  1    |         estimated at 3 billion Euro/year. The well-documented rise
472  III,    10.  4.  2    |         commodity combinations in 3 year cycles. In the future, besides
473  III,    10.  4.  2    |       agents to the Commission each year. The revised Community legislation
474  III,    10.  4.  2    |            is given for the current year and previous years. The
475  III,    10.  4.  2    |          The report for the current year is updated on a weekly basis.
476  III,    10.  4.  2    |            compared to the previous year, rising to an incidence
477  III,    10.  4.  2(34)|             minimum percentage each year, in order to ultimately
478  III,    10.  4.  2    |             130 cases of cancer per~year in the Netherlands~ ~ ~Research
479  III,    10.  4.  2    |             pesticides applied each year through the ten years arises
480  III,    10.  4.  2    |          MRLs set at EU level. Each year since 1996 monitoring recommendations
481  III,    10.  4.  2    |         commodity combinations in 3 year cycles. Currently pesticide
482  III,    10.  4.  2    |           samples are analysed each year for a wide range of pesticides;
483  III,    10.  4.  2    |        foodstuffs are surveyed each year depending on their dietary
484  III,    10.  4.  2    |           to be assessed within one year (Deadline: 01/09/2008).
485  III,    10.  4.  2    |           individually. (Deadline:1 year following the inclusion
486  III,    10.  4.  2    |      welfare and plant health. Each year a programme of FVO inspections
487  III,    10.  4.  2    |             out during the previous year. Both the multi-annual nationals
488  III,    10.  4.  3    |       EUGLOREH Countries. Data from year 2000~ ~ ~The under-five
489  III,    10.  4.  3    |              2002 or last available year~ ~The cause of water related
490  III,    10.  4.  3    |       status" for all waters by the year 2015. The purpose is to
491  III,    10.  4.  5    |             be introduced over a 13 year period, starting in 2008.~ ~
492  III,    10.  4.  5    |            20 tonnes per capita per year. This figure has been calculated
493  III,    10.  4.  5    |           generated in Europe every year, mostly in the EECCA countries,
494  III,    10.  4.  5    |             were sent to farms each year regardless of need. Stockpiles
495  III,    10.  5.  1    |         public health problem. Each year in the EU there are around
496  III,    10.  5.  1    |           and leisure accidents per year in selected EU countries).~ ~
497  III,    10.  5.  1    |           of seven outbreaks in one year, from 1998 to 2005 between
498  III,    10.  5.  1    |        outbreaks were observed each year. A total of 52 outbreaks (
499  III,    10.  5.  1    |        declined by 70%. In just one year after the ban, deaths from
500  III,    10.  5.  2    |             of male children is one year higher (66.4 years) in urban